Patient w ith endometriosis reporting less flare ups and symptom relieving under GLP-1 Medications
antioxidant defense pathway upregulation Regulatory status (as of publication): Not approved as a drug in the United States
The peptide does not appear to promote tumor growth in available research, though long-term human data remains limited
Contact your healthcare provider if you experience: Severe or persistent abdominal pain Continuous vomiting or dehydration Severe constipation lasting for several days Signs of low blood sugar levels (dizziness, confusion, lightheadedness, sweating, or rapid heartbeat) Allergic or hypersensitivity reaction (Symptoms of hypersensitivity reaction are skin rash, itching, urticaria (hives), flushing, shortness of breath, swelling of face, lips, and tongue, redness, sneezing, nasal congestion, watery eyes, cough, wheezing, chest tightness, dizziness, vomiting, abdominal pain, rapid heartbeat, and low blood pressure
Results vary by individual, but many patients see noticeable improvements within a few weeks of starting treatment